April 15, 2025

Serum fibrinogen is not elevated in patients with myasthenia gravis – Nature

April 15, 2025

Response of refractory residual ocular symptoms to efgartigimod in generalized myasthenia gravis: A real-world case series – ScienceDirect.com

April 13, 2025

Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience – Frontiers

April 9, 2025

New insights into how myasthenia gravis antibodies disrupt muscle function – News-Medical

April 8, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis – The New England Journal of Medicine